Neuroplasticity and the next wave of antidepressant strategies - Test2 - elhamkhani - TriplyDB

Neuroplasticity and the next wave of antidepressant strategies

Neuroplasticity and the next wave of antidepressant strategies

http://www.wikidata.org/entity/Q21129480

about

The neuroscience of depression: implications for assessment and intervention.Mechanisms Underlying the Antidepressant Response of Acupuncture via PKA/CREB Signaling Pathway.Antidepressant effects of resveratrol in an animal model of depression The role of ketamine in treatment-resistant depression: a systematic review.IFN-γ differentially modulates memory-related processes under basal and chronic stressor conditions.The effect of recombinant erythropoietin on plasma brain derived neurotrophic factor levels in patients with affective disorders: a randomised controlled study.Role of TrkB in the anxiolytic-like and antidepressant-like effects of vagal nerve stimulation: Comparison with desipramine.Efficacy of ketamine in the rapid treatment of major depressive disorder: a meta-analysis of randomized, double-blind, placebo-controlled studies.Common mechanisms of pain and depression: are antidepressants also analgesics?Pregnanolone Glutamate, a Novel Use-Dependent NMDA Receptor Inhibitor, Exerts Antidepressant-Like Properties in Animal Models.Multistage drug effects of ketamine in the treatment of major depression.Use of induced pluripotent stem cell derived neurons engineered to express BDNF for modulation of stressor related pathology.From Serotonin to Neuroplasticity: Evolvement of Theories for Major Depressive Disorder.The neuroimmune-neuroplasticity interface and brain pathology.Erythropoietin prevents the effect of chronic restraint stress on the number of hippocampal CA3c dendritic terminals-relation to expression of genes involved in synaptic plasticity, angiogenesis, inflammation, and oxidative stress in male rats.In vivo and in vitro effects of vortioxetine on molecules associated with neuroplasticity.Role and Possible Mechanisms of Sirt1 in Depression.GSK3β: a plausible mechanism of cognitive and hippocampal changes induced by erythropoietin treatment in mood disorders?

P2860

Q30399725-9105A029-CCFB-491C-A5DC-5C51EEC8B736 Q33623981-889AA99C-368B-49C5-88F4-A7583A50D0F1 Q33663230-8B0E105A-6695-4D35-90A2-21BF615C65CB Q34449588-34C4FFE9-0828-4CA4-89BA-9E1735BF9127 Q34547416-4391E442-B205-4134-894B-6F74EE447C58 Q35642010-0BD6CAE6-13BE-498A-9309-7AA4883474AC Q36756093-73C4BE9E-05AF-4B51-8876-6E08D15AE9E1 Q37398383-35C3FD44-887A-42DD-BB81-F326E5410D4C Q37676446-2773EF16-AC5A-4438-89B1-2DD142E20EA1 Q37718994-5F479E4B-CF63-41AB-BB1B-E2E600B54EE1 Q38248776-CB7A8706-9065-49B6-8B61-2E0CC5BEE0E5 Q42182695-223E8B77-EA6E-44D4-B226-4CAADA45F877 Q42369081-7B43B5B2-CA07-48DA-A070-F9406578DC3F Q43055038-75914389-CDBC-4F7E-A422-C710D88CE618 Q47813569-261D8641-213D-4779-BF3F-DB412F3ECB38 Q48494174-A9AD81F8-5BB5-492F-9BAC-DEA62F466182 Q52592883-99FB9CD3-D280-42A0-B344-A7803D4E2607 Q57477426-3EFB6CEA-806E-4BEA-B2A8-034C6131B1C2

P2860

Neuroplasticity and the next wave of antidepressant strategies

http://www.wikidata.org/entity/Q21129480

description

2013 nî lūn-bûn

@nan

2013 թուականին հրատարակուած գիտական յօդուած

@hyw

2013 թվականին հրատարակված գիտական հոդված

@hy

2013年の論文

@ja

2013年論文

@yue

2013年論文

@zh-hant

2013年論文

@zh-hk

2013年論文

@zh-mo

2013年論文

@zh-tw

2013年论文

@wuu

name

Neuroplasticity and the next wave of antidepressant strategies

@ast

Neuroplasticity and the next wave of antidepressant strategies

@en

Neuroplasticity and the next wave of antidepressant strategies

@en-gb

Neuroplasticity and the next wave of antidepressant strategies

@nl

type

label

Neuroplasticity and the next wave of antidepressant strategies

@ast

Neuroplasticity and the next wave of antidepressant strategies

@en

Neuroplasticity and the next wave of antidepressant strategies

@en-gb

Neuroplasticity and the next wave of antidepressant strategies

@nl

prefLabel

Neuroplasticity and the next wave of antidepressant strategies

@ast

Neuroplasticity and the next wave of antidepressant strategies

@en

Neuroplasticity and the next wave of antidepressant strategies

@en-gb

Neuroplasticity and the next wave of antidepressant strategies

@nl

P1433

Q21129480-B1962202-0053-4983-8976-62441C9EC379

P1476

Q21129480-1F1302F2-5811-4572-AFE2-F9BBA8A793EE

P2093

Q21129480-3793CBA5-F1DA-4F30-A885-A11F24A916B7

Q21129480-A5666122-658F-411F-B19F-CDD66FC402B1

P2860

Q21129480-00BA2628-6200-4750-915B-78E9076E7753

Q21129480-0135821C-918F-4021-8271-A08390DAC374

Q21129480-01E72BA0-041C-453E-AC17-736C5DD91F4A

Q21129480-033B5B9E-B690-4AE2-83F9-B009456DC4E0

Q21129480-04DAE839-33CE-4F85-AA18-9A7CDF445250

Q21129480-062265CB-AD92-4EF3-8805-BC3917855547

Q21129480-07E339B1-7B33-4D1F-9FC4-DCBE702B7966

Q21129480-0B18D31B-F5C3-4CDA-B6E6-5C606E59F21D

Q21129480-0C24DCB3-356E-4B55-8F81-F97D984B6582

Q21129480-0D2AF0B7-F3D5-416E-91BB-1B98A311C367

P304

Q21129480-E0FA2917-DADE-4124-8D4A-E51EC8385B63

P31

Q21129480-5F9304F5-4C6F-4E72-B06A-50A53339A5F2

P3181

Q21129480-905F3F8E-DE81-41A9-842C-78ABB8724CB0

P356

Q21129480-8996D1EA-FDFD-4078-96FC-D2CAA1A16A7E

P407

Q21129480-4E888D0C-BEF1-4649-B2B5-0749921987E6

P478

Q21129480-C9F1C4B3-140E-4EB4-9D41-C449C5948711

P577

Q21129480-D226F7E5-3FE8-420B-A995-83E0956D6E60

P5875

Q21129480-8A27831A-56D3-4C49-9B4F-6EE58A7B79FA

P698

Q21129480-0076F489-2B09-453B-8DF0-A5279D60B5AE

P921

Q21129480-E596B708-24EB-467F-8B4A-957C9AA4F340

P932

Q21129480-DFF453F1-4036-4BC1-9C6F-8902DBBFCAAF

P3181

P356

FNCEL.2013.00218

P1433

Frontiers in Cellular Neuroscience

P1476

Neuroplasticity and the next wave of antidepressant strategies

@en

P2093

Darcy Litteljohn

http://www.w3.org/2001/XMLSchema#string

Shawn Hayley

http://www.w3.org/2001/XMLSchema#string

P2860

Psychological therapies versus antidepressant medication, alone and in combination for depression in children and adolescents

Antidepressant effects of exercise: evidence for an adult-neurogenesis hypothesis?

A default mode of brain function

A Randomized, placebo-controlled, crossover pilot trial of the oral selective NR2B antagonist MK-0657 in patients with treatment-resistant major depressive disorder

Depression in multiple sclerosis: a review

Combination of pharmacotherapy and psychotherapy in the treatment of chronic depression: a systematic review and meta-analysis

The pleiotropic effects of erythropoietin in infection and inflammation

Cell atrophy and loss in depression: reversal by antidepressant treatment

Electroconvulsive therapy increases glial cell-line derived neurotrophic factor (GDNF) serum levels in patients with drug-resistant depression

Altered expression of neurotrophic factors in patients with major depression

P304

218

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P3181

2680759

http://www.w3.org/2001/XMLSchema#string

P356

10.3389/FNCEL.2013.00218

http://www.w3.org/2001/XMLSchema#string

P407

P478

7

http://www.w3.org/2001/XMLSchema#string

P577

2013-01-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

259208393

http://www.w3.org/2001/XMLSchema#string

P698

24312008

http://www.w3.org/2001/XMLSchema#string

P921

neuroplasticity

P932

3834236

http://www.w3.org/2001/XMLSchema#string